eTheRNA

0 followers


eTheRNA is developing innovative immuno-oncology therapies based on its unique APC-activating messenger RNA platform.

Industries

Headquarters

Stage

Employees

Links

Org chart

Bernard Sagaert
Interim CEO

Bernard Sagaert

Collapse
Steffen Helmling
Chief Business Officer
Dirk Van Broekhoven
VP, Corporate Management, General Counsel
Marina Cools
VP, Clinical Development
Michael Mulqueen
VP, Business Development
Stefaan De Koker
VP, Discovery
Phil Challis
VP, Product Development
Philip van der Auwera
VP Human Resources